Recently, Nanning Angel Investment Fund (hereinafter referred to as Angel Fund) has invested 5 million yuan toward Nanning Jiuren Jianxin Bio-tech Co., Ltd., marking the settling down of Angel Fund’s first investment project and promoting support of Angel Fund for innovative start-ups of the city.
The company is a bio-tech enterprise specializing in R&D, production and sales of cancer targeted drugs. With the success of the new project, it’s expected to contribute to transformation and industrialization of Nanning’s bio-medicine technology and promote high-quality development of the bio-medicine sector of the city. As to the next step, Nanning Financial Affairs Office will continue to utilize the leverage effect of government funds, guide entrusted agencies to do well in all kinds of work regarding Angel Fund, and encourage more social capital to be invested in the field of innovation and entrepreneurship investment in the city.